Sarepta Therapeutics, Inc. — Director's Dealing 2016

Oct 24, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2016-10-20

Reporting Person: Kaye Edward M. MD (Director, President, CEO & CMO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-10-20	Common Stock	F	4348	$49.05	Disposed	72635	Direct

Footnotes

F1: Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of restricted stock.